SEC Company Response from CarbonMeta Technologies, Inc. (CIK 0001156784) — Sep 27, 2005
CarbonMeta Technologies, Inc. (CIK 0001156784)
Date: Sept. 27, 2005 · CIK: 0001156784 · Accession: 0001144204-05-030059
AI Filing Summary & Sentiment
File numbers found in text: 333-127368
Referenced dates: September 2, 2005
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
Innova Holdings, Inc.
17105 San Carlos Boulevard, Suite A1651
Fort Myers, Florida 33931
September 27, 2005
Securities and Exchange Commission
Washington, D.C. 20549
Re: Innova Holdings, Inc. (the "Company")
Registration Statement on form SB-2
Filed August 9, 2005
File No. 333-127368
Form 10-KSB/A for Fiscal Year Ended December 31, 2004
Filed on July 29, 2005
Form 10-QSB/A for Fiscal Quarter Ended March 31, 2005
Filed on July 29, 2005
Form 10-QSB for Fiscal Quarter Ended June 30, 2005
Filed on August 22, 2005 File No. 0-33231
Gentlemen:
In response to your comment letter dated September 2, 2005, we have the
following responses that are keyed to your numbered comments:
Registration Statement on Form SB-2
General
Comment
1. We note the managing partner and general counsel of Cornell Capital
Partners serves as the escrow agent for the standby equity
distribution agreement. As such, it appears that this Cornell
affiliate in some circumstances exercises discretion with respect to
the release of shares or funds from the escrow. Section 7.a of the
escrow agreement, filed as Exhibit 10.18, suggests that the related
party escrow agent will be able to resolve the disputes under the
agreement to his sole satisfaction. In view of the relationship
between Cornell and the escrow agent and the functions of the escrow
agent with respect to closings of equity line draws, it appears that
Cornell exercises actual or potential discretion over the closings
and some control as to whether or when Cornell will perform against
advance notices from Innova Holdings. Provide your analysis of
whether this related party escrow agent arrangement provides
discretion to Cornell that is inconsistent with interpretation 4S of
the March 1999 supplement of the Division of Corporation Finance's
publicly available telephone interpretations. Specifically please
refer to the third Question and Answer of the Division of
Corporation Finance's March 2001 Supplement to the Division's
Current Issues Outline regarding "Private equity lines with
registered resales." For your review, both interpretative resources
are available at www.sec.gov.
1
<PAGE>
Response
1. In response to your comment, Cornell Capital Partners and the
Company have agreed to have Baxter, Baker, Sidle, Conn & Jones,
P.A., an independent law firm, serve as the escrow agent under the
Escrow Agreement. None of the members of this firm are affiliated
with Cornell Capital Partners. A copy of the Escrow Agreement is
attached to this letter as Exhibit A. A copy of the Escrow Agreement
will also be attached as an exhibit to the amendment to form SB-2
when it is filed. Also attached to this letter as Exhibit B is the
agreement between Innova Holdings, Inc. and Cornell Capital Partners
substituting a new escrow agent for David Gonzalez, Esq. in response
to the Staff's comment.
Selling Stockholders, page 13
Comment
2. We note your inclusion of Monitor Capital, Inc. as a selling
shareholder who is a non-natural person. Further, it appears that
this selling shareholder is a broker-dealer. Tell us whether this
broker-dealer received the securities as underwriting compensation.
Please note that a registration statement registering the resale of
shares being offered by a broker-dealer must identify the
broker-dealer as an underwriter if the shares were not issued as
transaction-based compensation provided in connection with the
performance of investment banking services. If the shares were
earned for services of this type provide appropriate disclosure of
the transaction, the services provided and the compensatory
arrangement.
Response
2. In response to the comment, we will add the following disclosure of
the transaction between Monitor Capital, Inc. and the Company that
sets forth the nature of the transaction, the services provided and
the compensatory arrangement, to the Selling Shareholders section of
the amendment to the SB-2 when it is filed:
"On June 14, 2005, Innova entered into a Placement Agent Agreement
with Monitor Capital, Inc., a registered broker-dealer. Under the
Placement Agent Agreement, the Placement Agent agreed to provide us
with services consisting of reviewing the terms of the Equity
Distribution Agreement and advising the Company with respect to
those terms. Pursuant to the Placement Agent Agreement, Innova paid
a one-time placement agent fee of 289,855 restricted shares of
common stock equal to approximately $10,000 based on Innova's stock
price on May 4, 2005, when the term sheet for the Equity
Distribution Agreement was signed. This registration statement
includes the 289,855 shares received by Monitor Capital, Inc., as
its one-time fee under the Placement Agent Agreement."
2
<PAGE>
Form 10-KSB/A for Fiscal Year Ended December 31, 2004 filed on July 29, 2005
Item 8a. Controls and Procedures, page 22
Form 10-QSB/A for Fiscal Quarter Ended March 31, 2005 filed on July 29, 2005
Item 3. Controls and Procedures, page 13
Comment
3. We note your disclosure that your principal executive officer and
principal financial officer initially concluded that your Company's
controls and procedures were effective, but as indicated in your
Form 10-KSB/A, management concluded that your disclosure controls
and procedures were ineffective regarding accounting for beneficial
conversion features associated with convertible preferred securities
and the guidance provided by EITF 98-5 and EITF 00-27. Pursuant to
Item 307 of Regulation S-B, your principal executive and principal
financial officers must disclose their conclusions as to the
effectiveness of your disclosure controls and procedures. Revise
your Form 10-KSB/A and 10-QSB/A to state whether these controls and
procedures were effective without including any limitations as to
scope.
Response
3. We have attached to this letter as Exhibit C. revised disclosure of
the "Controls and Procedures" section in our Form 10-KSB/A for the
year ended December 31, 2004, Form 10-QSB/A for the quarter ended
March 31, 2005 and Form 10-QSB for the quarter ended June 30, 2005.
These revised sections are in response to comments 3 through 7.
Comment
4. Similarly, we note that both your December 31, 2004 Form 10-KSB and
March 31, 2005 Form 10-QSB disclose that management initially
concluded your controls and procedures to be effective, but then
after a reevaluation as of December 31, 2004 and March 31, 2005
determined your disclosure controls and procedures to be ineffective
regarding the accounting for beneficial conversion features
associated with convertible preferred securities. A scope limitation
as to your effectiveness evaluation is not appropriate. If you
determined your disclosure controls and procedures were ineffective
as of December 31, 2004, state this unambiguously. Please also
revise both periodic reports to more fully describe the remedial
actions you plan to take or have taken to address the deficiencies
in your disclosure controls and procedures. Also, provide a
chronology as to when the accounting problems were discovered and
explain how this information was learned.
3
<PAGE>
Response
4. We have attached to this letter as Exhibit C revised disclosure of
the "Controls and Procedures" section in our Form 10-KSB/A for the
year ended December 31, 2004, Form 10-QSB/A for the quarter ended
March 31, 2005 and Form 10-QSB for the quarter ended June 30, 2005.
These revised sections are in response to comments 3 through 7.
Comment
5. We note your restatements of the financial statements and the
changes in internal control over financial reporting. Please revise
both periodic reports to expressly describe all material weaknesses
and your restatement of financial statements rather than simply
referring to amended financial statements and deficiencies in
general. Please revise to explain why your accounting treatment of
the beneficial conversion features and any other material weaknesses
resulted in a change to your internal control over financial
reporting. Refer to Item 308(c) of Regulation S-B and Sections D.
and E. of the Division of Corporation Finance and Office of the
Chief Accountant: Staff's Statement on Management's Report on
Internal Control Over Financial Reporting (May 16, 2005).
Response
5. We have attached to this letter as Exhibit C revised disclosure of
the "Controls and Procedures" section in our Form 10-KSB/A for the
year ended December 31, 2004, Form 10-QSB/A for the quarter ended
March 31, 2005 and Form 10-QSB for the quarter ended June 30, 2005.
These revised sections are in response to comments 3 through 7.
Comment
6. We note your disclosure that management has implemented "certain
improvements and changes" in the Company's internal control over
financial reporting. Please revise both periodic reports to describe
the remedial measures undertaken concerning your internal control
over financial reporting, when you implemented these measure and
when you anticipate full implementation of these corrective
measures. Refer to item 308(c) of Regulation S-B.
Response
6. We have attached to this letter as Exhibit C revised disclosure of
the "Controls and Procedures" section in our Form 10-KSB/A for the
year ended December 31, 2004, Form 10-QSB/A for the quarter ended
March 31, 2005 and Form 10-QSB for the quarter ended June 30, 2005.
These revised sections are in response to comments 3 through 7.
4
<PAGE>
Form 10-QSB for Fiscal Quarter Ended June 30, 2005 filed on August 22, 2005
Item 3. Controls and Procedures, page 13
Comment
7. Based on your disclosure at the end of this section referring to no
other change, please revise your disclosure to articulate the change
in internal control over financial reporting and the remedial
measures implemented during this period ended June 30, 2005. Refer
to Exchange Act Rule 13a-15(b) and Item 308(c) of Regulation S-B.
Response
7. We have attached to this letter as Exhibit C revised disclosure of
the "Controls and Procedures" section in our Form 10-KSB/A for the
year ended December 31, 2004, Form 10-QSB/A for the quarter ended
March 31, 2005 and Form 10-QSB for the quarter ended June 30, 2005.
These revised sections are in response to comments 3 through 7.
Sincerely,
By: /s/ Walter Weisel
--------------------------------------
Walter Weisel
Chief Executive Officer
5
<PAGE>
EXHIBIT A
ESCROW AGREEMENT
THIS ESCROW AGREEMENT (this "Agreement") is made and entered into as of
September 26, 2005 by INNOVA HOLDINGS, INC., a Delaware corporation (the
"Company"); CORNELL CAPITAL PARTNERS, LP, a Delaware limited partnership (the
"Investor"); and BAXTER, BAKER, SIDLE, CONN & JONES, P.A. (the "Escrow Agent").
BACKGROUND
WHEREAS, the Company and the Investor have entered into a Standby Equity
Distribution Agreement (the "Standby Equity Distribution Agreement") dated June
14, 2005, pursuant to which the Investor will purchase common stock, par value
$0.001 per share of the Company (the "Common Stock"), at a price per share equal
to the Purchase Price, as that term is defined in the Standby Equity
Distribution Agreement, for an aggregate price of up to Ten Million Dollars
($10,000,000). The Standby Equity Distribution Agreement provides that on each
Advance Date the Investor, as that term is defined in the Standby Equity
Distribution Agreement, shall deposit the Advance pursuant to the Advance Notice
in an escrow account to be held by the Escrow Agent and the Company shall
deposit shares of the Company's Common Stock, which shall be purchased by the
Investor as set forth in the Standby Equity Distribution Agreement, with the
Escrow Agent, in order to effectuate a disbursement to the Company of the
Advance by the Escrow Agent and a disbursement to the Investor of the shares of
the Company's Common Stock by Escrow Agent at a closing to be held as set forth
in the Standby Equity Distribution Agreement (the "Closing"). (All capitalized
terms not otherwise defined herein shall have the meaning assigned to them in
the Standby Equity Distribution Agreement.)
WHEREAS, the Company, the Investor, and David Gonzalez, Esq. entered into
an escrow agreement ("Initial Escrow Agreement") on June 14, 2005 pursuant to
which David Gonzalez, Esq. was to serve as escrow agent in connection with the
Standby Equity Distribution Agreement. On the date hereof, the Company and the
Investor entered into an agreement pursuant to which David Gonzalez, Esq. was
removed as the escrow agent and the Initial Escrow Agreement was terminated.
WHEREAS, Escrow Agent has agreed to accept, hold, and disburse the funds
and the shares of the Company's Common Stock deposited with it in accordance
with the terms of this Agreement.
WHEREAS, in order to establish the escrow of funds and shares to effect
the provisions of the Standby Equity Distribution Agreement, the parties hereto
have entered into this Agreement.
NOW THEREFORE, in consideration of the foregoing, it is hereby agreed as
follows:
1. Definitions. The following terms shall have the following meanings when
used herein:
<PAGE>
a. "Escrow Funds" shall mean the Advance funds deposited with the
Escrow Agent pursuant to this Agreement.
b. "Joint Written Direction" shall mean a written direction executed
by the Investor and the Company directing Escrow Agent to disburse all or a
portion of the Escrow Funds or to take or refrain from taking any action
pursuant to this Agreement.
c. "Common Stock Joint Written Direction" shall mean a written
direction executed by the Investor and the Company directing the Escrow Agent to
disburse all or a portion of the shares of the Com